Acer Therapeutics Inc., which has merged with Opexa Therapeutics Inc., appointed William Andrews as chief medical officer to replace Robert Steiner.
Previously, Andrews held senior leadership positions and positions of increasing responsibility at Aegerion Pharmaceuticals Inc., Santhera Pharmaceuticals Holding AG, Sepracor, and ClinQuest.